OpenURL Connection Search

Select item for more details and to access through your institution.

Capsaicin causes cell-cycle arrest and apoptosis in ER-positive and -negative breast cancer cells by modulating the EGFR/HER-2 pathway.
Published in:
Oncogene, 2010, v. 29, n. 2, p. 285, doi. 10.1038/onc.2009.335
By:
- Thoennissen, N. H.;
- O'Kelly, J.;
- Lu, D.;
- Iwanski, G. B.;
- La, D. T.;
- Abbassi, S.;
- Leiter, A.;
- Karlan, B.;
- Mehta, R.;
- Koeffler, H. P.
Publication type:
Article
Functional variant of KLOTHO: a breast cancer risk modifier among BRCA1 mutation carriers of Ashkenazi origin.
Published in:
Oncogene, 2010, v. 29, n. 1, p. 26, doi. 10.1038/onc.2009.301
By:
- Wolf, I.;
- Laitman, Y.;
- Rubinek, T.;
- Abramovitz, L.;
- Novikov, I.;
- Beeri, R.;
- Kuro-O, M.;
- Koeffler, H. P.;
- Catane, R.;
- Freedman, L. S.;
- Levy-Lahad, E.;
- Karlan, B. Y.;
- Friedman, E.;
- Kaufman, B.
Publication type:
Article
Klotho: a tumor suppressor and a modulator of the IGF-1 and FGF pathways in human breast cancer.
Published in:
Oncogene, 2008, v. 27, n. 56, p. 7094, doi. 10.1038/onc.2008.292
By:
- Wolf, I.;
- Levanon-Cohen, S.;
- Bose, S.;
- Ligumsky, H.;
- Sredni, B.;
- Kanety, H.;
- Kuro-o, M.;
- Karlan, B.;
- Kaufman, B.;
- Koeffler, H. P.;
- Rubinek, T.
Publication type:
Article
The risk of breast cancer in <italic>BRCA1</italic> and <italic>BRCA2</italic> mutation carriers without a first‐degree relative with breast cancer.
Published in:
Clinical Genetics, 2018, v. 93, n. 5, p. 1063, doi. 10.1111/cge.13191
By:
- and the Hereditary Breast Cancer Clinical Study Group;
- Metcalfe, K. A.;
- Senter, L.;
- Narod, S. A.;
- Eisen, A.;
- Sun, P.;
- Lubinski, J.;
- Gronwald, J.;
- Huzarski, T.;
- McCuaig, J.;
- Lynch, H. T.;
- Karlan, B.;
- Foulkes, W. D.;
- Singer, C. F.;
- Neuhausen, S. L.
Publication type:
Article
YAP modifies cancer cell sensitivity to EGFR and survivin inhibitors and is negatively regulated by the non-receptor type protein tyrosine phosphatase 14.
Published in:
Oncogene, 2013, v. 32, n. 17, p. 2220, doi. 10.1038/onc.2012.231
By:
- Huang, J-M;
- Nagatomo, I;
- Suzuki, E;
- Mizuno, T;
- Kumagai, T;
- Berezov, A;
- Zhang, H;
- Karlan, B;
- Greene, M I;
- Wang, Q
Publication type:
Article
Altered expression of transforming growth factor-beta ligands and receptors in primary and recurrent ovarian carcinoma.
Published in:
1999
By:
- Bristow, R E;
- Baldwin, R L;
- Yamada, S D;
- Korc, M;
- Karlan, B Y
Publication type:
journal article
Perioperative coagulopathy in patients undergoing primary cytoreduction.
Published in:
1993
By:
- Brown, John V.;
- Karlan, Beth Y.;
- Greenspoon, Jeffrey S.;
- Rosove, Michael H.;
- Lagasse, Leo D.;
- Brown, J V;
- Karlan, B Y;
- Greenspoon, J S;
- Rosove, M H;
- Lagasse, L D
Publication type:
journal article
Integrated genomic analyses of ovarian carcinoma.
Published in:
Nature, 2011, v. 474, n. 7353, p. 609, doi. 10.1038/nature10166
By:
- Bell, D.;
- Berchuck, A.;
- Birrer, M.;
- Chien, J.;
- Cramer, D. W.;
- Dao, F.;
- Dhir, R.;
- DiSaia, P.;
- Gabra, H.;
- Glenn, P.;
- Godwin, A. K.;
- Gross, J.;
- Hartmann, L.;
- Huang, M.;
- Huntsman, D. G.;
- Iacocca, M.;
- Imielinski, M.;
- Kalloger, S.;
- Karlan, B. Y.;
- Levine, D. A.
Publication type:
Article
Foxc2 induces Wnt4 and Bmp4 expression during muscle regeneration and osteogenesis.
Published in:
Cell Death & Differentiation, 2013, v. 20, n. 8, p. 1031, doi. 10.1038/cdd.2013.34
By:
- Gozo, M C;
- Aspuria, P-J;
- Cheon, D-J;
- Walts, A E;
- Berel, D;
- Miura, N;
- Karlan, B Y;
- Orsulic, S
Publication type:
Article
Indole-3-carbinol synergistically sensitises ovarian cancer cells to bortezomib treatment.
Published in:
British Journal of Cancer, 2012, v. 106, n. 2, p. 333, doi. 10.1038/bjc.2011.546
By:
- Taylor-Harding, B;
- Agadjanian, H;
- Nassanian, H;
- Kwon, S;
- Guo, X;
- Miller, C;
- Karlan, B Y;
- Orsulic, S;
- Walsh, C S
Publication type:
Article

Found: 10